Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

713.71
-1.4900-0.21%
Post-market: 714.000.2900+0.04%19:59 EDT
Volume:2.64M
Turnover:1.88B
Market Cap:676.41B
PE:60.95
High:719.64
Open:710.00
Low:709.00
Close:715.20
Loading ...

Press Release: Lilly declares second-quarter 2025 dividend

Dow Jones
·
06 May

Eli Lilly First Quarter 2025 Earnings: EPS Misses Expectations

Simply Wall St.
·
04 May

Investing.com’s stocks of the week

Investing.com
·
03 May

Eli Lilly Is Maintained at Buy by UBS

Dow Jones
·
03 May

Eli Lilly Stock Offers Buying Opportunity For Goldman Sachs. Concerns Over CVS Setback Are Overblown, Analysts Say

Benzinga
·
03 May

Trump Says Drug Tariffs Are Coming. Big Pharma Execs Can't Figure Out How Much to Worry. -- Barrons.com

Dow Jones
·
03 May

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

Motley Fool
·
02 May

Eli Lilly's Stock Selloff Is Overdone, Analysts Say. Here's Why. -- Barrons.com

Dow Jones
·
02 May

Eli Lilly's Zepbound Likely to Continue Uptake Despite CVS Decision, Truist Says

MT Newswires Live
·
02 May

Eli Lilly's 'Untapped Volume' in Obesity Drug Counters CVS Setback, Deutsche Bank Says

MT Newswires Live
·
02 May

Eli Lilly stock sell-off was 'overrreaction': Analysts

Yahoo Finance
·
02 May

Eli Lilly and Company to Join Bank of America Securities 2025 Healthcare Conference

Reuters
·
02 May

Lilly to participate in Bank of America Securities 2025 Healthcare Conference

PR Newswire
·
02 May

Pharma Stocks Rallied. Novo-Nordisk up 6%; Eli Lilly and Viking up 4%; Moderna, Novavax And BioNTech up 1%.

Tiger Newspress
·
02 May

Eli Lilly Shares up 4.3% After 11.7% Decline in Previous Session

THOMSON REUTERS
·
02 May

BUZZ-Street View: Eli Lilly well positioned in weight-loss market despite CVS's decision

Reuters
·
02 May

UBS Adjusts Price Target on Eli Lilly to $1,050 From $1,100, Maintains Buy Rating

MT Newswires Live
·
02 May

Truist Financial Remains a Buy on Eli Lilly & Co (LLY)

TIPRANKS
·
02 May

Eli Lilly : Morgan Stanley Raises Target Price to $1133 From $1124

THOMSON REUTERS
·
02 May

Company News for May 2, 2025

Zacks
·
02 May